Evidence from animal and human studies demonstrates that GLP-1 RAs improve mitochondrial function, reduce oxidative stress, attenuate chronic inflammation, and enhance autophagic activity
Attendees included several clinicians who prescribe peptides, a peptide manufacturer, the founder of a longevity DAO, a Stanford researcher, and dozens of people who identified as "peptide curious," searching for either the resources or confidence to build their own "stacks." Another 300 had been waitlisted
Typically, the eligibility criteria for GLP-1 medication are: a body mass index (BMI) score of 30 or over a BMI of 27 or over and a weight-related health condition The weight-related health conditions can include those such as diabetes, high cholesterol, or high blood pressure
Biochemical genetic workup showed persistently low free carnitine levels both on dried bloodspots and in serum, in the presence of normal renal L-carnitine fractional excretion (Table 1)